Episode 183 | Rick Geoffrion, President & CEO at Cyrano Therapeutics and Chip Hance, CEO at Regatta Medical | The History and Importance of the Early Feasibility Studies (EFS) Program at the FDA
- Author
- Project Medtech
- Published
- Mon 10 Jun 2024
- Episode Link
- https://podcasters.spotify.com/pod/show/projectmedtech/episodes/Episode-183--Rick-Geoffrion--President--CEO-at-Cyrano-Therapeutics-and-Chip-Hance--CEO-at-Regatta-Medical--The-History-and-Importance-of-the-Early-Feasibility-Studies-EFS-Program-at-the-FDA-e2kk4l4
In this episode, Rick Geoffrion at Cyrano Therapeutics and Chip Hance at Regatta Medical and Duane Mancini discuss history of the Early Feasibility Studies (EFS) Program at the @FDA, the importance of it, how @MDIC supported mission and so much more.
